Preventing weight gain in young adults
This study tests a program to help young adults with a family history of obesity avoid gaining weight. It involves checking if certain health conditions or medications would make the program unsafe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 25 years old.
- Your body mass index (BMI) is between 25 and 30 (overweight range).
- At least one biological parent has severe obesity (BMI 35 or higher) or both parents have obesity (BMI 30 or higher).
- You do not have diabetes, have not had weight-loss surgery, and are not taking certain medications that affect weight or insulin.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you are willing to use two forms of birth control if sexually active.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two medications, phentermine and topiramate, to see if they help young people with hypothalamic obesity lose weight safely. Hypothalamic obesity is rapid weight gain caused by injury to the hypothalamus, often from a brain tumor or its treatment.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests a program to help people with obesity lose weight. It looks at how well the program works and if it is safe for participants.
This trial tests a program to help overweight or obese young adults lose weight using a mobile device. It aims to see if you can reverse obesity with diet and lifestyle changes.
This early-stage trial tests how safe and tolerable CMS-D008, an experimental weight-management medicine, is in healthy adults who are overweight or obese. Researchers will gradually increase the dose to find the right amount and monitor how your body responds.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.